Finance

Lists
Why is 532834 up 5,20%?
Dive Deeper
532834:BOM
Camlin Fine Sciences Ltd
94,71 INR
+5,20%
(+4,68) 1D
16 ოქტ, 13:17:36 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
89,52 INR
High
98,00 INR
Low
89,43 INR
Mkt. cap
18,21 მლრდ.
Avg. vol.
45,48 ათ.
Volume
193,83 ათ.
P/E ratio
334,31
52-wk high
204,35 INR
52-wk low
88,27 INR
EPS
0,28 INR
Shares outstanding
121,25 მლნ.
No. of employees
674
Open
89,52 INR
High
98,00 INR
Low
89,43 INR
Mkt. cap
18,21 მლრდ.
Avg. vol.
45,48 ათ.
Volume
193,83 ათ.
P/E ratio
334,31
52-wk high
204,35 INR
52-wk low
88,27 INR
EPS
0,28 INR
Shares outstanding
121,25 მლნ.
No. of employees
674
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees674
Founded1931
Headquarters-
SectorSpeciality chemicals
Last report
11 აგვ. 2026
Fiscal period
Q1 2027
-0,99 INR / 0,12 INR
-921,17%miss
Revenue / Est. (INR)
5,20 მლრდ. / 5,11 მლრდ.
+1,66%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,60 მლრდ.
4,57 მლრდ.
3,83 მლრდ.
5,20 მლრდ.
Cost of goods sold
2,47 მლრდ.
2,48 მლრდ.
2,24 მლრდ.
3,06 მლრდ.
Cost of revenue
2,47 მლრდ.
2,48 მლრდ.
2,24 მლრდ.
3,06 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
602,93 მლნ.
637,64 მლნ.
886,99 მლნ.
734,29 მლნ.
Operating expense
1,99 მლრდ.
2,04 მლრდ.
1,52 მლრდ.
2,16 მლრდ.
Total operating expenses
4,45 მლრდ.
4,52 მლრდ.
3,76 მლრდ.
5,21 მლრდ.
Operating income
145,85 მლნ.
53,04 მლნ.
65,46 მლნ.
-15,12 მლნ.
Other non operating income
17,20 მლნ.
29,36 მლნ.
-94,79 მლნ.
13,40 მლნ.
EBT including unusual items
-923,00 ათ.
-278,54 მლნ.
2,25 მლნ.
-322,59 მლნ.
EBT excluding unusual items
-923,00 ათ.
-103,43 მლნ.
94,48 მლნ.
-211,49 მლნ.
Income tax expense
59,12 მლნ.
452,00 ათ.
-64,02 მლნ.
-4,63 მლნ.
Effective tax rate
-6 405,31%
-0,16%
-2 849,31%
1,44%
Other operating expenses
1,19 მლრდ.
1,23 მლრდ.
449,93 მლნ.
1,23 მლრდ.
Net income
-143,84 მლნ.
-362,30 მლნ.
882,02 მლნ.
-317,06 მლნ.
Net profit margin
-3,13%
-7,92%
23,05%
-6,10%
Earnings per share
-0,29
-0,94
0,76
-0,99
Interest and investment income
-
-
79,64 მლნ.
-
Interest expense
-152,05 მლნ.
-183,29 მლნ.
-76,78 მლნ.
-162,78 მლნ.
Net interest expenses
-152,05 მლნ.
-183,29 მლნ.
2,86 მლნ.
-162,78 მლნ.
Depreciation and amortization charges
188,27 მლნ.
167,28 მლნ.
184,44 მლნ.
191,56 მლნ.
EBITDA
324,59 მლნ.
203,20 მლნ.
199,10 მლნ.
118,52 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები